Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT02307474
What this trial is testing

A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00422786
What this trial is testing

Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Thallion Pharmaceuticals 10
Post-approval studies (Phase 4)Ended earlyNCT02338570
What this trial is testing

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)

Who this might be right for
Renal Cell Carcinoma
Mario Negri Institute for Pharmacological Research 31
Testing effectiveness (Phase 2)Ended earlyNCT01673386
What this trial is testing

A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc. 58
Testing effectiveness (Phase 2)Study completedNCT03967522
What this trial is testing

Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 26
Early research (Phase 1)UnknownNCT05468190
What this trial is testing

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Study completedNCT00378703
What this trial is testing

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 361
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Testing effectiveness (Phase 2)Study completedNCT03294083
What this trial is testing

Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
SillaJen, Inc. 95
Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Testing effectiveness (Phase 2)UnknownNCT00890110
What this trial is testing

Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib

Who this might be right for
Renal Cell Cancer
Hadassah Medical Organization 13
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Large-scale testing (Phase 3)Study completedNCT00018941
What this trial is testing

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Early research (Phase 1)WithdrawnNCT03189186
What this trial is testing

Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas

Who this might be right for
Renal Cell CarcinomaMetastatic Kidney Cancer
University of California, Irvine
Large-scale testing (Phase 3)Study completedNCT00606632
What this trial is testing

Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Heidelberg Pharma AG 226
Very early researchStudy completedNCT00276835
What this trial is testing

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Northwestern University 15
Early research (Phase 1)Study completedNCT00351949
What this trial is testing

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Who this might be right for
Stage IV Renal Cell Carcinoma
Immutep S.A.S. 24
Large-scale testing (Phase 3)Study completedNCT00003126
What this trial is testing

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Loyola University 69
Testing effectiveness (Phase 2)Study completedNCT00045487
What this trial is testing

Erlotinib in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
The University of Texas Health Science Center at San Antonio 41
Next Page